*** New Software Coming Soon! Please Check for Important Information in the Read Me Section ***
-
Posts
19,771 -
Joined
-
Last visited
-
Days Won
1 -
Points
0 [ Donate ]
Content Type
Profiles
Forums
Store
Downloads
Blogs
Competitions
Everything posted by happyone
-
Ridge--he said virtually the same thing just above with this post.
-
I do not deny that there is an uptick in the number of infections and in some areas hospitalizations. IMO there is a correlation between unsafe personal practices--ie masks and social distancing. The new infections, according to reports, are from the new strain G614 which is more infectious and spreads more rapidly than the previous D614, but it is not making people any sicker than before.
-
Dave, COVID has no power to close businesses. All it can do is make people sick, The only thing that closed down business and the economy was the government leaders, who were persuaded by the "scientific community" to quarantine everyone. Now that it did happen, the leaders, some scientists, and especially the media continue the fear campaign to scare everyone into submission.
-
Masha General Chat Topic #4 2020 May/July
happyone replied to happyone's topic in Masha (10/13/15 - 08/22/24)
Maybe she doesn't shower or bathe because she thinks we like dirty girls--😏 -
Masha General Chat Topic #4 2020 May/July
happyone replied to happyone's topic in Masha (10/13/15 - 08/22/24)
It is quite obvious that our sexy helper because of her constant itching and rubbing the dead skin from her body needs a good cleansing bath or shower -
I believe, Dave, that if you read his piece, he is talking to the politicians and so called scientists who have brought this economic hardship upon the USA and sums up his article by this statement "𝗬𝗢𝗨𝗥 fear is not an excuse to destroy America. 𝗬𝗢𝗨𝗥 fear is not my fear and your fear does not have the right to interfere with my life, my job, my income or my future as a free American citizen" . And you part in red ---the pandemic has not brought this hardship, it is as Nugent tries to point out the leaders, politicians, "scientists", and the media who are using fear as a tool that have caused the result we are now experiencing.
-
Masha General Chat Topic #4 2020 May/July
happyone replied to happyone's topic in Masha (10/13/15 - 08/22/24)
Right now she is only dreaming about it 😏 -
B2 Girls on Vacation - General Topic 2020 #11 (June/July)
happyone replied to Noldus's topic in B#2 Astra, Ivy (08/02/16)
When you think about it--isn't that what is done almost daily in this forum by some--???? 😏 -
Chat continues on July 3, 2020
-
Unless possibly they go to emergency and such treatment with this drug is part of the emergency treatment---however, this is a stupid response on my part-- because in the USA you will get treated in the emergency room for Covid19--but the average cost you will be charged is around US $73,000 for a 6 day stay. However, most people do not realize they can negotiate this down to approximately what Medicare would pay the provider at about US $10,561. Still, that is a lot of fucking money to most people and why massive health care reform is needed in this country.
-
Gilead donates Covid-19 drug remdesivir to Australia’s medical stockpile after US buys up supply | Australia news | The Guardian WWW.THEGUARDIAN.COM US bought more than 500,000 doses, representing all of Gilead’s production for July and 90% of August and September Just days after getting conditional approval for its coronavirus drug remdesivir in Europe, Gilead has announced pricing for the U.S. and other developed countries, charging different rates for the U.S. federal government and private insurers. In an open letter obtained by Fox News, Gilead Sciences CEO and Chairman Daniel O'Day said the price per vial of remdesivir would be $390 for government health care programs in developed countries, such as Medicare, equal to $2,340 per patient on a short, six-vial treatment. For private insurance companies, the price would be $520 per vial, or $3,120 for a six-vial treatment. According to other sources that I have read, the pricing decision was based on a savings of about US $12,000.00 due to decrease in hospital stay, Gilead says this savings to the health care system is the basis for the pricing. IMO these pharmaceutical companies are scalping the public with their pricing as it only costs Gilead about US $6.00 to produce a six day treatment.
-
There are 2 drugs shown that they could be effective--and the USA did buy 500,000 doses from Gilead, a US company, which put the product in short supply for 3 months. But your post in bold is a lie. Here is the article from BBC news. Short supply By Richard Warry, BBC News While there is international concern about the US buying up almost all supplies of remdesivir, we must remember that Gilead is a US company, and that the country has recorded the highest number of cases and deaths from Covid-19. Under US law, export of drugs considered essential to treatment of patients in a public health emergency can be banned - and many other countries, including the UK, have similar legal provisions. Gilead has put in place voluntary licensing agreements with a number of manufacturers around the world with the aim of producing the drug for use in developing nations. In extremis, there is also a compulsory licensing mechanism which could allow countries to ignore Gilead's intellectual property rights, and manufacture their own generic versions of the drug. However, the US deal will inevitably mean that for the next three months at least the drug - one of only two that have so far been of proven benefit for patients who are seriously ill with Covid-19 - will be in short supply in many other countries. The UK, however, says it currently has sufficient stocks for patients who need it. The US is among several countries to approve remdesivir for use in combating Covid-19. The European Union is expected to give approval this week, according to Germany's health ministry. Germany says it has sufficient supplies of the drug and expects to be able to acquire more from Gilead in the future. In the UK, the Department of Health said it had enough to treat every National Health Service patient who needed it.
